The company may from time to time, in one or more offerings at prices and on terms that it will determine at the time of each offering, sell common stock, warrants, or a combination of these securities, or units, up to a total offering price of $200M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RENB:
- Renovaro BioSciences presents insights on Oxford Nanopore sequencing
- Renovaro BioSciences announces strategic restructuring, leadership transition
- Renovaro Biosciences Appoints New CEO and Board Members
- Renovaro BioSciences, PersonalAIze announce strategic partnership
- PersonalAIze conducted evaluation on Renovaro’s RenovaroCube